Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: Identify the Optimal TMS Target to Modulate Reward Activity [NA]

View source ↗

Summary

Rutgers is recruiting for a study to identify the optimal transcranial magnetic stimulation (TMS) target to modulate reward activity in nicotine use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Nicotine Use Disorder | NA | Status: RECRUITING